OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
20
Results
Show all
Save search
Copy query
Show results for
Unknown
(20)
Publication Date
Release Date
2021
(7)
2024
(5)
2022
(3)
2025
(2)
2023
(2)
2020
(1)
Previous
page
1 / 2
You're on page
1
page
2
Next
page
Sort
by:
Relevance
Page size
10
Cross-ancestry atlas of gene, isoform, and splicing regulation in the developing human brain.
Not available
S-EPMC12147038
|
biostudies-literature
Cite
Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind, randomised, controlled, phase 2/3 trial.
Not available
S-EPMC7674972
|
biostudies-literature
Cite
Single-cell genomics and regulatory networks for 388 human brains.
Not available
S-EPMC11365579
|
biostudies-literature
Cite
Massively parallel characterization of regulatory elements in the developing human cortex.
Not available
S-EPMC12085231
|
biostudies-literature
Cite
Single-cell multi-cohort dissection of the schizophrenia transcriptome.
Not available
S-EPMC12772489
|
biostudies-literature
Cite
A data-driven single-cell and spatial transcriptomic map of the human prefrontal cortex.
Not available
S-EPMC11398705
|
biostudies-literature
Cite
Dexamethasone in Hospitalized Patients with Covid-19.
Not available
S-EPMC7383595
|
biostudies-literature
Cite
Effect of Hydroxychloroquine in Hospitalized Patients with Covid-19.
Not available
S-EPMC7556338
|
biostudies-literature
Cite
Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.
Not available
S-EPMC7884931
|
biostudies-literature
Cite
Plasma AR Alterations and Timing of Intensified Hormone Treatment for Prostate Cancer: the STAMPEDE Phase 3 Randomized Clinical Trial.
Not available
S-EPMC11869088
|
biostudies-literature
Cite
Previous
page
1 / 2
You're on page
1
page
2
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets